Apollon Formularies (AQSE:APOL) Price-to-Tangible-Book : 0.03 (As of Jun. 01, 2024)

View and export this data going back to . Start your Free Trial

What is Apollon Formularies Price-to-Tangible-Book?

As of today (2024-06-01), Apollon Formularies's share price is £8.0E-5. Apollon Formularies's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was £0.00. Hence, Apollon Formularies's Price to Tangible Book Ratio of today is 0.03.

The historical rank and industry rank for Apollon Formularies's Price-to-Tangible-Book or its related term are showing as below:

During the past 11 years, Apollon Formularies's highest Price to Tangible Book Ratio was 6.63. The lowest was 0.01. And the median was 1.06.

AQSE:APOL's Price-to-Tangible-Book is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 2.33
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Apollon Formularies's share price is £8.0E-5. Apollon Formularies's Book Value per Sharefor the quarter that ended in Jun. 2023 was £0.00. Hence, Apollon Formularies's P/B Ratio of today is 0.03.

Apollon Formularies Price-to-Tangible-Book Historical Data

The historical data trend for Apollon Formularies's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollon Formularies Price-to-Tangible-Book Chart

Apollon Formularies Annual Data

Trend

Jun10

Jun11

Dec12

Dec13

Dec14

Dec17

Dec18

Dec19

Dec20

Dec21

Price-to-Tangible-Book

Get a 7-Day Free Trial

0.01

2.92

1.06

6.63

Apollon Formularies Semi-Annual Data
	Jun11	Jun12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Jun23
Price-to-Tangible-Book	Get a 7-Day Free Trial											1.06	0.30	6.63	4.50	0.58

Competitive Comparison of Apollon Formularies's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Apollon Formularies's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apollon Formularies's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Apollon Formularies's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Apollon Formularies's Price-to-Tangible-Book falls into.

Apollon Formularies Price-to-Tangible-Book Calculation

Apollon Formularies's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jun. 2023 )
	=	8.0E-5	/	0.003
	=	0.03

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Apollon Formularies Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Apollon Formularies's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollon Formularies (AQSE:APOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apollon Formularies PLC (AQSE:APOL) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Hope Street, Quayside House, Castletown, IMN, IM9 1AS

Website

https://www.apollon.org.uk

Apollon Formularies PLC is a London, England and Jamaican based medical cannabis pharmaceutical company specialising in research and treatment of patients with cancer and chronic pain. It is engaged in investing by seeking to acquire a direct and/or indirect interest in projects and assets in the agriculture and logistics sectors and the medicinal cannabis sector. The company focus on opportunities in Africa and Europe. It has created proprietary hybrid medical cannabis pharmaceutical strains, technology, formulations, and treatment products.